Company intelligence / Profile preview
Mingji Biopharmaceutical
Beijing, Beijing, Chinamingjibio.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Mingji Biopharmaceutical is a clinical-stage biotechnology company based in Beijing, China, specializing in the development of innovative cell therapies and antibody-based drugs. The company focuses on chimeric antigen receptor T-cell (CAR-T) therapies for both hematological malignancies and solid tumors, utilizing its proprietary M-CAR technology platform to enhance safety and efficacy. Its lead programs include CD19-targeted CAR-T for lymphomas and BCMA-targeted therapies for multiple myeloma. Mingji is also expanding its pipeline into solid tumor indications, targeting antigens such as Claudin-18.2 and Mesothelin. The company aims to provide next-generation immunotherapy solutions through integrated R&D and manufacturing capabilities.
- Therapeutic areas
- Oncology
- Modalities
- CAR-T cell therapyCell therapyMonoclonal antibodyAntibody
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Mingji Biopharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mingji Biopharmaceutical.